Physician profile
Gregory Joseph Kirchner
NPI 1073140760
$6,579.23
in general payments reported to CMS, 2019-2025
8 companies · $5,438 in 2025
The $5,438 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $30.15 · 2023: $439 · 2024: $672 · 2025: $5,438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,000 · Food and Beverage: $1,374 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,000.00 |
| Food and Beverage | $1,374.09 |
| Education | $174.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,000.00 | 2025 | |
| Stryker Corporation | $563.80 | 2022-2025 | Mako, X3, Tritanium |
| Novus Surgical Consultants | $402.52 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $197.66 | 2025 | Comprehensive Shoulder System |
| Innovation Technologies INC | $163.62 | 2023 | Irrisept |
| Avanos Medical | $146.83 | 2023 | On-Q* Pump and Accessories |
| Depuy Synthes Sales INC. | $71.81 | 2024-2025 | Na, Lcp |
| Treace Medical Concepts, INC. | $32.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Kirchner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.